NCT00461929View on ClinicalTrials.gov

Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib

PHASE4TerminatedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Chronic Myeloid LeukemiaGastrointestinal Stromal Cell TumorsChromosome Abnormality
Interventions
PROCEDURE

bone marrow aspiration

Trial Locations (2)

M5G 2M9

Mount Sinai Hospital, Toronto

Princess Margaret Hospital, Toronto

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

collaborator

Mount Sinai Hospital, Canada

OTHER

collaborator

Novartis

INDUSTRY

lead

University Health Network, Toronto

OTHER